Fluperlapine in 104 schizophrenic patients. Open multicenter trial.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Arzneimittel-Forschung

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-1-4613-2363-1_124PMID 6145428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A short survey on untoward effects of fluperlapine.

  1984cited by this paper
• [Multifocal psychopharmaceutic testing ("Multihospital trial")].

  1974cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• The Role of Myeloperoxidase in Clozapine-Induced Inflammation: A Mechanistic Update for Idiosyncratic Drug-Induced Agranulocytosis

  2023cites this paper
• Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART II

  2009cites this paper
• Effects of fluperlapine on dopaminergic systems in rat brain

  2004cites this paper
• N-OXIDATION OF DRUGS ASSOCIATED WITH IDIOSYNCRATIC DRUG REACTIONS

  2002cites this paper
• Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.

  2001cites this paper
• Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions?

  2000cites this paper
• Activation is Hallucinogenic and Antagonism is Therapeutic: Role of 5-HT2A Receptors in Atypical Antipsychotic Drug Actions

  1999cites this paper
• The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis.

  1998cites this paper
• Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.

  1996cites this paper
• Common profile of D1 receptor antagonists and atypical antipsychotic drugs revealed by analysis of dopamine turnover.

  1994cites this paper
• Clozapine in the treatment of tremor in Parkinson's disease

  1994cites this paper
• Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs.

  1993cites this paper
• Extrapyramidal Symptoms and their Relationship to Clinical Efficacy under Perphenazine Treatment*

  1991cites this paper
• 5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade.

  1990cites this paper
• Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs.

  1990cites this paper
• Clozapine: New research on efficacy and mechanism of action

  1989cites this paper
• Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat

  1987cites this paper
• Differential Effects of a New Dibenzo-Epine Neuroleptic Compared with Haloperidol Results of an Open and Crossover Study

  1987cites this paper
• Determination of fluperlapine in human plasma by capillary gas chromatography.

  1987cites this paper
• Biochemical and pharmacological effects of fluperlapine on noradrenaline and acetylcholine systems in some rodent, bovine and crustacean preparations

  1986cites this paper
• Tricyclic epines. Novel (E)- and (Z)-11H-dibenz[b,e]azepines as potential central nervous system agents. Variation of the basic side chain.

  1986cites this paper
• Recent news in the chemistry and pharmacology of neuroleptics with special regard to the work carried out in Czechoslovakia.

  1986cites this paper
• Fluperlapine vs Haloperidol: A Comparison of their Neuroendocrinological Profiles and the Influence on Serum Lipids

  1986cites this paper
• Central antiserotonin action of fluperlapine.

  1985cites this paper
• Pharmaco-EEG studies with fluperlapine.

  1984cites this paper